OCGN Ocugen 8-K2021Regulation FD Disclosure
5 Jan 21
Content Analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
|
|
OCGN 8-K Filings
- 12 Jan 21 Submission of Matters to a Vote of Security Holders
- 8 Jan 21 Other Events
- 5 Jan 21 Regulation FD Disclosure
- 28 Dec 20 Submission of Matters to a Vote of Security Holders
- 22 Dec 20 Ocugen and Bharat Biotech TO Co-DEVELOP COVAXIN™, a Whole-Virion Inactivated COVID-19 Vaccine, for the US market
- 6 Nov 20 Regulation FD Disclosure
Filing View
Search this filing
Table of Contents
Get all this for free
- Email alerts for new filings that match keywords or companies
- Plot, compare & download financial data
- 10-K & 10-Q redlined comparisons
- Advanced filing search & analysis
- Sentiment analysis for financial filings
- Favorites, search history, and more…